BIOAVENGE

BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of genes and gene expression, and genetic sequences of biological significance into a gene discovery, functional analysis, and identification of bio hazardous agents. It also utilizes its technology for target validation, screening bio hazardous contamination, diagnostic applications, and prophylactic and therapeutic vaccine development. The company was founded in 2000 and is based in Gaithersburg, Maryland. As of February 12, 2008, BioAvenge operates as a subsidiary of GateKeeper USA, Inc. (OTCPK:GTKP).